Insulin Resistance and Cognitive Impairment: Evidence From Neuroimaging

• Published in: Journal of magnetic resonance imaging 2022-12, Vol.56 (6), p.1621-1649
• Main Authors: Cui, Ying, Tang, Tian‐Yu, Lu, Chun‐Qiang, Ju, Shenghong
• Format: Article
• Language: English
• Subjects: Abnormalities; Alzheimer Disease - metabolism; Alzheimer's disease; Brain; Brain - pathology; Cognition & reasoning; Cognitive ability; Cognitive Dysfunction - complications; cognitive impairment; Cortex (cingulate); Cortex (parietal); Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Executive function; functional MRI; Glucose; Glucose metabolism; Humans; Impairment; Insulin; Insulin resistance; Insulin Resistance - physiology; Insulins - metabolism; Magnetic Resonance Imaging; Medical imaging; Metabolic disorders; Metabolism; Neurodegeneration; Neurodegenerative diseases; Neuroimaging; Neuroimaging - methods; Neuronal-glial interactions; Occipital lobe; Pathophysiology; Prefrontal cortex; Risk analysis; Risk factors; Structure-function relationships; Substantia alba; Substrates; Temporal cortex; Temporal lobe
• ISSN: 1053-1807; 1522-2586
• DOI: 10.1002/jmri.28358

Insulin is a peptide well known for its role in regulating glucose metabolism in peripheral tissues. Emerging evidence from human and animal studies indicate the multifactorial role of insulin in the brain, such as neuronal and glial metabolism, glucose regulation, and cognitive processes. Insulin resistance (IR), defined as reduced sensitivity to the action of insulin, has been consistently proposed as an important risk factor for developing neurodegeneration and cognitive impairment. Although the exact mechanism of IR‐related cognitive impairment still awaits further elucidation, neuroimaging offers a versatile set of novel contrasts to reveal the subtle cerebral abnormalities in IR. These imaging contrasts, including but not limited to brain volume, white matter (WM) microstructure, neural function and brain metabolism, are expected to unravel the nature of the link between IR, cognitive decline, and brain abnormalities, and their changes over time. This review summarizes the current neuroimaging studies with multiparametric techniques, focusing on the cerebral abnormalities related to IR and therapeutic effects of IR‐targeting treatments. According to the results, brain regions associated with IR pathophysiology include the medial temporal lobe, hippocampus, prefrontal lobe, cingulate cortex, precuneus, occipital lobe, and the WM tracts across the globe. Of these, alterations in the temporal lobe are highly reproducible across different imaging modalities. These structures have been known to be vulnerable to Alzheimer's disease (AD) pathology and are critical in cognitive processes such as memory and executive functioning. Comparing to asymptomatic subjects, results are more mixed in patients with metabolic disorders such as type 2 diabetes and obesity, which might be attributed to a multifactorial mechanism. Taken together, neuroimaging, especially MRI, is beneficial to reveal early abnormalities in cerebral structure and function in insulin‐resistant brain, providing important evidence to unravel the underlying neuronal substrate that reflects the cognitive decline in IR. Evidence Level 5 Technical Efficacy Stage 2